Key facts
- It has raised $1.5M across 1 recorded rounds; the latest was Seed Round ($1.5M) in Mar 2026.
- HumanImage has filed 1 Form D with the SEC, most recently Apr 2026 ($1.5M sold to 20 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 1 rounds
- ·Watchlist + deal alerts for HumanImage
Funding rounds
1 roundsAbout HumanImage
Developer of a 3D imaging system designed for the earliest possible detection and tracking of skin cancer through life-size surface avatars. The company offers 3D scanning to create life-size replicas of the human body, enabling clinicians to identify subtle skin changes and detect malignancies even beneath tattoos, significantly accelerating intervention and maximizing patient cure rates.
- Sector
- Healthcare
- HQ
- Chicago, IL, United States
- Founded
- 2021
- Website
- humanimageinc.com/
- Ownership
- Privately Held (backing)
HumanImage doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in HumanImage shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on HumanImage in its N-PORT filings yet. We sweep new filings monthly.